D

Precision BioSciences

DTIL

9.47400
USD
-0.026
(-0.27%)
مغلق
حجم التداول
1,364
الربح لكل سهم
0
العائد الربحي
0
P/E
34
حجم السوق
64,452,802
أصول ذات صلة
A
ADPT
-0.13000
(-2.85%)
4.43000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NSTG
0
(0%)
0.000000 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
R
RGNX
-0.920
(-6.44%)
13.370 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
T
TECH
0.790
(0.97%)
82.360 USD
V
VYGR
-0.59000
(-6.37%)
8.67000 USD
Z
ZYME
-0.340
(-3.25%)
10.120 USD
الأخبار المقالات

العنوان: Precision BioSciences

القطاع: Healthcare
الصناعة: Biotechnology
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.